BCV
AGIO icon

Banque Cantonale Vaudoise’s Agios Pharmaceuticals AGIO Stock Holding History

Banque Cantonale Vaudoise’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-317
Closed -$11K – 1067
2020
Q3 		$11K Buy
+317
New +$13.9K ﹤0.01% 1006

Other funds holding AGIO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Banque Cantonale Vaudoise's AGIO Position: Q4 2020 in Review

Banque Cantonale Vaudoise sold out of Agios Pharmaceuticals (AGIO) in Q4 2020, closing a stake of 317 shares — an estimated $11K sold.

Banque Cantonale Vaudoise first reported a position in AGIO in Q3 2020 and held it in 1 quarter. The position peaked at $11K in Q3 2020. 200 funds tracked by Wall St. Rank hold AGIO as of Q4 2020.

  • Banque Cantonale Vaudoise reported no remaining Agios Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Banque Cantonale Vaudoise sold 317 Agios Pharmaceuticals shares in Q4 2020, an estimated $11K.
  • Banque Cantonale Vaudoise first reported a position in Agios Pharmaceuticals in Q3 2020 and held it in 1 quarter.
  • Banque Cantonale Vaudoise's Agios Pharmaceuticals position peaked at $11K in Q3 2020.
  • 200 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2020.

Based on Banque Cantonale Vaudoise's 13F filing for Q4 2020, filed 5 Feb 2021.